Mucinous endometrial cancer: Clinical study of the eleven cases.
Endometrial carcinoma
mucinous type
survival
Journal
Northern clinics of Istanbul
ISSN: 2536-4553
Titre abrégé: North Clin Istanb
Pays: Turkey
ID NLM: 101684520
Informations de publication
Date de publication:
2020
2020
Historique:
received:
26
04
2017
accepted:
16
04
2019
entrez:
2
4
2020
pubmed:
2
4
2020
medline:
2
4
2020
Statut:
epublish
Résumé
In this study, we analyzed surgico-pathologic factors of mucinous type endometrial carcinoma and examined its frequency of recurrence. In this study, eleven cases, definitely diagnosed as pure mucinous type endometrium carcinoma between January 1993 and May 2013, were reviewed. Of 1640 women with endometrium carcinoma, 11 (0.67%) of them had a mucinous cell type. Mean age of the study group was 55 years. According to the FIGO 2009, 10 (90.9%) cases were evaluated as stage I and 1 (9.1%) as stage IIIC1. The presence of lymph node metastasis was noticed in only one (12.5%) of eight patients who underwent lymphadenectomy. In this case, metastasis was detected in the pelvic lymph node. Four patients underwent adjuvant therapy as pelvic radiotherapy. Median follow-up time was 50 months (range, 5-84). Recurrence was observed in one (9.1%) patient with stage IIIC1 endometrial cancer in 30 months after primary surgery. The site of recurrence was only in the upper abdominal region. Based on our study, mucinous endometrial carcinoma has good prognostic factors, and long term survival can be achieved surgically alone in patients with stage I.
Identifiants
pubmed: 32232205
doi: 10.14744/nci.2019.17048
pii: NCI-7-60
pmc: PMC7103747
doi:
Types de publication
Journal Article
Langues
eng
Pagination
60-64Informations de copyright
Copyright: © 2020 by Istanbul Northern Anatolian Association of Public Hospitals.
Déclaration de conflit d'intérêts
Conflict of Interest: No conflict of interest was declared by the authors.
Références
Gynecol Oncol. 1983 Feb;15(1):10-7
pubmed: 6822361
Oncologist. 2014 Jun;19(6):645-53
pubmed: 24821823
Cancer Control. 2009 Jan;16(1):46-52
pubmed: 19078929
Gynecol Oncol. 1982 Jun;13(3):373-92
pubmed: 6284595
Gynecol Oncol. 2004 Mar;92(3):744-51
pubmed: 14984936
Adv Anat Pathol. 2004 May;11(3):117-42
pubmed: 15096727
Am J Surg Pathol. 1983 Dec;7(8):715-29
pubmed: 6318581
Int J Gynecol Pathol. 1987;6(4):347-55
pubmed: 2826354
Am J Clin Oncol. 2016 Feb;39(1):43-8
pubmed: 24390270
Gynecol Oncol. 2012 Jun;125(3):541-5
pubmed: 22410328
Int J Cancer. 2015 Mar 1;136(5):E359-86
pubmed: 25220842
Gynecol Oncol. 2008 Jan;108(1):226-33
pubmed: 17996926
Obstet Gynecol. 1980 Feb;55(2):244-7
pubmed: 6243410
Mod Pathol. 1999 Dec;12(12):1137-42
pubmed: 10619266
Int J Gynecol Cancer. 2012 Jun;22(5):812-8
pubmed: 22569105
Am J Surg Pathol. 1980 Oct;4(5):481-9
pubmed: 7435776
Br J Cancer. 2006 Aug 7;95(3):266-71
pubmed: 16868539
J Reprod Med. 2014 Nov-Dec;59(11-12):527-33
pubmed: 25552123